Topic: David Dean

Modern Family" . The Directors Guild of America announced the nominations in the television and commercial categories on Tuesday, with Modern ...

QLT Inc. (QLTI) Q1 2010 Earnings Call May 06, 2010 8:30 am ET. Turning briefly to our commercial efforts for Visudyne in the U.S., we've had our sales team in place since January and the team completed their first ...

QLT Inc. (QLTI) Q4 2009 Earnings Call March 10, 2010 8:30 am ET. Presenting today is Bob Butchofsky our President and CEO and Cameron Nelson, our CFO. I'll give an overview of the clinical data for the punctal plug drug ...

QLT, Inc. (QLTI) Q4 2008 Earnings Call February 19, 2009 8:30 am ET. However while Visudyne sales declined last year, we were successful in getting a higher profit share percentage of sales from Novartis last year than in 2007.. For those ...

QLT Inc. (QLTI) Q2 2008 Earnings Call July 29, 2008 8:30 am ET. The risks that future sales per products maybe less than unexpected, uncertainties related to costs and success of R&D, commercialization of products and litigation and certainly related to the timing and ability to invest assets and accept terms and prices and other future unknown liabilities and other factors including those described in QLT's annual report on form 10-K, quarterly reports on form 10-Q and other filings at the US and Canadian securities regulatory authorities.. Global Visudyne sales in the second quarter were $40.7 million which is a quarter-over-quarter increase of approximately 12% and it is the first meaningful quarter-over-quarter gain we had in Visudyne in over three years. Cam will highlight the sales breakdown in his section of the call but we were pleased with the quarter and continue to remain on track to meet our yearend Visudyne sales guidance of $145 million to $160 million although we expect to see the usual seasonal dip in Visudyne sales in the third quarter with the rebound in the fourth quarter.. Worldwide sales in the second quarter were $60.3 million with growth of about 34% from last year. The regional split for second quarter Visudyne sales was US, $10.1 million; Europe, $14.3 million and rest of the world ...